1. Home
  2. KMDA vs RMT Comparison

KMDA vs RMT Comparison

Compare KMDA & RMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • RMT
  • Stock Information
  • Founded
  • KMDA 1990
  • RMT 1993
  • Country
  • KMDA Israel
  • RMT United States
  • Employees
  • KMDA N/A
  • RMT N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • RMT Investment Managers
  • Sector
  • KMDA Health Care
  • RMT Finance
  • Exchange
  • KMDA Nasdaq
  • RMT Nasdaq
  • Market Cap
  • KMDA 392.2M
  • RMT 460.2M
  • IPO Year
  • KMDA N/A
  • RMT N/A
  • Fundamental
  • Price
  • KMDA $6.84
  • RMT N/A
  • Analyst Decision
  • KMDA Strong Buy
  • RMT
  • Analyst Count
  • KMDA 2
  • RMT 0
  • Target Price
  • KMDA $13.00
  • RMT N/A
  • AVG Volume (30 Days)
  • KMDA 56.5K
  • RMT 111.5K
  • Earning Date
  • KMDA 11-12-2025
  • RMT 01-01-0001
  • Dividend Yield
  • KMDA 2.92%
  • RMT 7.37%
  • EPS Growth
  • KMDA 27.97
  • RMT N/A
  • EPS
  • KMDA 0.32
  • RMT 1.49
  • Revenue
  • KMDA $169,517,000.00
  • RMT N/A
  • Revenue This Year
  • KMDA $14.49
  • RMT N/A
  • Revenue Next Year
  • KMDA $10.12
  • RMT N/A
  • P/E Ratio
  • KMDA $20.74
  • RMT $6.18
  • Revenue Growth
  • KMDA 9.67
  • RMT N/A
  • 52 Week Low
  • KMDA $5.18
  • RMT $7.67
  • 52 Week High
  • KMDA $9.16
  • RMT $9.51
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 41.12
  • RMT N/A
  • Support Level
  • KMDA $6.50
  • RMT N/A
  • Resistance Level
  • KMDA $6.89
  • RMT N/A
  • Average True Range (ATR)
  • KMDA 0.13
  • RMT 0.00
  • MACD
  • KMDA -0.01
  • RMT 0.00
  • Stochastic Oscillator
  • KMDA 38.50
  • RMT 0.00

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About RMT Royce Micro-Cap Trust Inc.

Royce Micro-Cap Trust Inc is a diversified closed-end investment company. The company is engaged in investing in micro-cap securities. It invests in the consumer discretionary sector including auto components, automobiles, diversified consumer services, hotels, restaurants and leisure, household durables, internet and catalog retail, leisure products, media, multiline retail, textiles, apparels, and luxury goods, Consumer staples sector including beverages, food, and staples retailing, food products, and personal products, Energy sector including energy equipment and services, and oil, gas, and consumable fuels. The company also invests in other sectors including healthcare, financials, industrials, IT, telecommunications, and materials.

Share on Social Networks: